CPI-169EZH2 inhibitor CAS# 1450655-76-1 |
- 3-Deazaneplanocin,DZNep
Catalog No.:BCC1129
CAS No.:102052-95-9
- 3-Deazaneplanocin A (DZNep) hydrochloride
Catalog No.:BCC3604
CAS No.:120964-45-6
- GSK343
Catalog No.:BCC1607
CAS No.:1346704-33-3
- EPZ005687
Catalog No.:BCC2219
CAS No.:1396772-26-1
- EI1
Catalog No.:BCC4044
CAS No.:1418308-27-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1450655-76-1 | SDF | Download SDF |
PubChem ID | 78357814 | Appearance | Powder |
Formula | C27H36N4O5S | M.Wt | 528.66 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 59 mg/mL (111.60 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 1-[1-(1-ethylsulfonylpiperidin-4-yl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methylindole-3-carboxamide | ||
SMILES | CCS(=O)(=O)N1CCC(CC1)C(C)N2C(=C(C3=CC=CC=C32)C(=O)NCC4=C(C=C(NC4=O)C)OC)C | ||
Standard InChIKey | LHGUZCKPFXXVPV-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C27H36N4O5S/c1-6-37(34,35)30-13-11-20(12-14-30)18(3)31-19(4)25(21-9-7-8-10-23(21)31)27(33)28-16-22-24(36-5)15-17(2)29-26(22)32/h7-10,15,18,20H,6,11-14,16H2,1-5H3,(H,28,33)(H,29,32) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
CPI-169 Dilution Calculator
CPI-169 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.8916 mL | 9.4579 mL | 18.9157 mL | 37.8315 mL | 47.2894 mL |
5 mM | 0.3783 mL | 1.8916 mL | 3.7831 mL | 7.5663 mL | 9.4579 mL |
10 mM | 0.1892 mL | 0.9458 mL | 1.8916 mL | 3.7831 mL | 4.7289 mL |
50 mM | 0.0378 mL | 0.1892 mL | 0.3783 mL | 0.7566 mL | 0.9458 mL |
100 mM | 0.0189 mL | 0.0946 mL | 0.1892 mL | 0.3783 mL | 0.4729 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].
CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). In addition, CPI-169 has been reported to reduce cellular levels of histone H3 on lysine 27(H3K27) with an EC50 value of 70nM. Moreover, CPI-169 has been exhibited to trigger cell cycle arrest and apoptosis in cells. Apart from these, treatment the inhibitor at 200mpk twice daily, CPI-169 has been noted to have a well tolerated in mice with no observed toxic effect or body weight loss [1].
References:
[1] Vidya Balasubramanian, Priya Iyer, Shilpi Arora, Patrick Troyer, Emmanuel Normant. Constellation Pharmaceuticals, Cambridge, MA. CPI-169, a novel and potent EZH2 inhibitor, synergizes with CHOP in vivo and achieves complete regression in lymphoma xenograft models
- Candesartan cilexetil
Catalog No.:BCC8900
CAS No.:145040-37-5
- FGIN-1-43
Catalog No.:BCC6739
CAS No.:145040-29-5
- Fmoc-Asp(OMe)-OH
Catalog No.:BCC3090
CAS No.:145038-53-5
- Digalactosyldiacylglycerol
Catalog No.:BCC8941
CAS No.:145033-48-3
- ω-Agatoxin IVA
Catalog No.:BCC7488
CAS No.:145017-83-0
- Pregnenolone
Catalog No.:BCN6255
CAS No.:145-13-1
- DGAT1-IN-1
Catalog No.:BCC5511
CAS No.:1449779-49-0
- DDR1-IN-1
Catalog No.:BCC5170
CAS No.:1449685-96-4
- Boeravinone O
Catalog No.:BCN6693
CAS No.:1449384-21-7
- Chlojaponilactone B
Catalog No.:BCN7400
CAS No.:1449382-91-5
- K145 hydrochloride
Catalog No.:BCC4072
CAS No.:1449240-68-9
- Senexin B
Catalog No.:BCC3990
CAS No.:1449228-40-3
- Rink Amide Linker
Catalog No.:BCC2833
CAS No.:145069-56-3
- YM 022
Catalog No.:BCC7052
CAS No.:145084-28-2
- Filicenol B
Catalog No.:BCN6446
CAS No.:145103-37-3
- Piribedil dihydrochloride
Catalog No.:BCC6898
CAS No.:1451048-94-4
- Dexmedetomidine HCl
Catalog No.:BCC4347
CAS No.:145108-58-3
- 8-Hydroxy-PIPAT oxalate
Catalog No.:BCC6800
CAS No.:1451210-48-2
- 6-Hydroxykaempferol-3,6,7-triglucoside
Catalog No.:BCN1562
CAS No.:145134-62-9
- 6-Hydroxykaempferol 3-Rutinoside -6-glucoside
Catalog No.:BCN1561
CAS No.:145134-63-0
- CP 99994 dihydrochloride
Catalog No.:BCC6016
CAS No.:145148-39-6
- 3beta-Hydroxyporiferast-5-en-7-one
Catalog No.:BCN6256
CAS No.:145163-97-9
- Iodophenpropit dihydrobromide
Catalog No.:BCC6793
CAS No.:145196-87-8
- Kaliotoxin
Catalog No.:BCC7710
CAS No.:145199-73-1